The Cambridge Gene-Editing Biotech Success Story: Horizon Discovery is Doubling in Size with new HQ

28/10/2015 - 2 minutes

Horizon Discovery is a gene-editing tools specialist with various biotech partnerships over their cell-line catalogues. A UK expansion for Horizon is now underway, with the launch of a new genomics eCommerce webshop and the expansion of their headquarters.

logoHorizon Discovery provides personalized translational medicine products and services, such as bespoke cell-lines for drug discovery and gene-editing tools for the biotech industry. Their website is a great resource for gene-editing publications as well, and is now a functional ‘shop’ for over 20,000 cell-line catalogues and in vivo models.

Partners include Cambridge’s Abcam (whose co-founder Milner also invested in Horizon), for which Horizon’s cell lines will be used in discovery of new antibodies for immunotherapies. Horizon also partnered with Thermo Fischer Scientific earlier this year, who have licensed use of their X-MAN cell lines for cancer research.

Horizon Discovery explains how it is committed to the Cambridge biotech community for the long-term, despite now having other offices across the US and Austria,

This content is available exclusively to our paying members.

Our members receive the following benefits:

  • Unlock premium articles
  • Download our industry reports
  • Remove all banner ads
  • Access 1,500+ archived posts
  • Support our independent media
Already a member? Sign in
ADVERTISEMENT
Do you want to remove this advert? Become a member!
ADVERTISEMENT
Do you want to remove this advert? Become a member!